What is Rentokil Initial Plc's earnings per share (EPS)?

Rentokil Initial Plc (RTO) reported diluted earnings per share of $0.11 for fiscal year 2025. This represents a -16.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Rentokil Initial Plc Financials

RTO

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Rentokil Initial Plc (RTO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RTO FY2025 2026-04-22

Cash generation outpaces accounting profit, and an acquisition-shaped balance sheet still operates with little debt pressure.

In FY2025, operating cash flow reached $972M against $470M of net income, and the same cash-over-profit pattern held in each of the prior two years. With capex only $208M and goodwill still at $6.6B, the company looks lightly capital-intensive today but heavily shaped by past acquisitions rather than by physical reinvestment.

The liquidity dip in FY2024 looks more like working-capital timing than funding strain: the current ratio fell below 1.0x, but cash recovered to $2.3B in FY2025. Because long-term debt stayed around $392M, short-term tightness did not come with a meaningful increase in leverage.

Free cash flow covered dividends comfortably in FY2025, at $764M versus $304M, so shareholder payouts were funded internally rather than by added borrowing. That matters because company-level cash generation stayed resilient even when reported profit dipped, so the distribution policy appears tied more to cash capacity than to any single year's earnings figure.

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Rentokil Initial Plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Rentokil Initial Plc's revenue grew a modest 4.4% year-over-year to $6.9B. This slow but positive growth earns a score of 40/100.

Leverage

100

Rentokil Initial Plc carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Rentokil Initial Plc's current ratio of 1.16 is below the typical benchmark, resulting in a score of 18/100. However, the company holds substantial cash reserves (70% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow

Rentokil Initial Plc has a free cash flow margin of 11.1%, earning a moderate score of 52/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Rentokil Initial Plc's ROE of 8.6% shows moderate profitability relative to equity, earning a score of 30/100. This is up from 7.4% the prior year.

Earnings Quality Cash-Backed

2.07x

For every $1 of reported earnings, Rentokil Initial Plc generates $2.07 in operating cash flow ($972.0M OCF vs $470.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.9B

YoY+4.4%

Rentokil Initial Plc generated $6.9B in revenue in fiscal year 2025. This represents an increase of 4.4% from the prior year.

EBITDA

N/A

Net Income

$470.0M

YoY+19.9%

Rentokil Initial Plc reported $470.0M in net income in fiscal year 2025. This represents an increase of 19.9% from the prior year.

EPS (Diluted)

$0.11

YoY-16.4%

Rentokil Initial Plc earned $0.11 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 16.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$764.0M

YoY+17.7%

Rentokil Initial Plc generated $764.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 17.7% from the prior year.

Cash & Debt

$2.3B

YoY+100.3%

Rentokil Initial Plc held $2.3B in cash against $392.0M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

2.53B

YoY+0.1%

Rentokil Initial Plc had 2.53B shares outstanding in fiscal year 2025. This represents an increase of 0.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

6.8%

YoY+0.9pp

Rentokil Initial Plc's net profit margin was 6.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.9 percentage points from the prior year.

Return on Equity

8.6%

YoY+1.1pp

Rentokil Initial Plc's ROE was 8.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$208.0M

YoY-5.0%

Rentokil Initial Plc invested $208.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.0% from the prior year.

RTO Income Statement

Metric	FY25	FY24	FY23
Revenue	$6.9B+4.4%	$6.6B+3.6%	$6.4B
Cost of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A
Interest Expense	$31.0M0.0%	$31.0M+3.3%	$30.0M
Income Tax	$100.0M-13.8%	$116.0M-10.1%	$129.0M
Net Income	$470.0M+19.9%	$392.0M-17.3%	$474.0M
EPS (Diluted)	$0.11-16.4%	$0.14-20.8%	$0.17

Metric	Q4'25	Q4'24	Q4'23
Revenue	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A
Net Income	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A

RTO Balance Sheet

Metric	FY25	FY24	FY23
Total Assets	N/A	N/A	N/A
Current Assets	$3.9B+47.8%	$2.6B-24.0%	$3.4B
Cash & Equivalents	$2.3B+100.3%	$1.2B-41.8%	$2.0B
Inventory	$308.0M+7.3%	$287.0M+8.7%	$264.0M
Accounts Receivable	$1.2B+1.2%	$1.1B+1.4%	$1.1B
Goodwill	$6.6B+2.0%	$6.5B-28.0%	$9.0B
Total Liabilities	N/A	N/A	N/A
Current Liabilities	$3.3B+2.8%	$3.2B-1.8%	$3.3B
Long-Term Debt	$392.0M-0.5%	$394.0M-2.7%	$405.0M
Total Equity	$5.5B+3.8%	$5.3B+1.6%	$5.2B
Retained Earnings	$6.4B+3.5%	$6.2B+1.9%	$6.1B

Metric	Q4'25	Q4'24	Q4'23
Total Assets	N/A	N/A	N/A
Current Assets	$3.9B+47.8%	$2.6B-24.0%	$3.4B
Cash & Equivalents	$2.3B+100.3%	$1.2B-41.8%	$2.0B
Inventory	$308.0M+7.3%	$287.0M+8.7%	$264.0M
Accounts Receivable	$1.2B+1.2%	$1.1B+1.4%	$1.1B
Goodwill	$6.6B+2.0%	$6.5B-28.0%	$9.0B
Total Liabilities	N/A	N/A	N/A
Current Liabilities	$3.3B+2.8%	$3.2B-1.8%	$3.3B
Long-Term Debt	$392.0M-0.5%	$394.0M-2.7%	$405.0M
Total Equity	$5.5B+3.8%	$5.3B+1.6%	$5.2B
Retained Earnings	$6.4B+3.5%	$6.2B+1.9%	$6.1B

RTO Cash Flow Statement

Metric	FY25	FY24	FY23
Operating Cash Flow	$972.0M+12.0%	$868.0M-5.2%	$916.0M
Capital Expenditures	$208.0M-5.0%	$219.0M+5.8%	$207.0M
Free Cash Flow	$764.0M+17.7%	$649.0M-8.5%	$709.0M
Investing Cash Flow	$26.0M+105.5%	-$476.0M+7.4%	-$514.0M
Financing Cash Flow	$27.0M+102.8%	-$952.0M-111.1%	-$451.0M
Dividends Paid	$304.0M+4.1%	$292.0M+15.9%	$252.0M
Share Buybacks	N/A	N/A	N/A

Metric	Q4'25	Q4'24	Q4'23
Operating Cash Flow	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A

RTO Financial Ratios

Metric	Q4'25	Q4'24	Q4'23
Gross Margin	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A
Current Ratio	1.16+0.4	0.81-0.2	1.05
Debt-to-Equity	0.070.0	0.070.0	0.08
FCF Margin	N/A	N/A	N/A

Similar Companies

UL Solutions ULS

$20.1B

Aramark US ARMK

$14.0B

Global Pmts Inc GPN

$20.2B

RB Global Ord Shs RBA

$19.7B

Relx Plc RELX

$58.4B

Frequently Asked Questions

What is Rentokil Initial Plc's annual revenue?

Rentokil Initial Plc (RTO) reported $6.9B in total revenue for fiscal year 2025. This represents a 4.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Rentokil Initial Plc's revenue growing?

Rentokil Initial Plc (RTO) revenue grew by 4.4% year-over-year, from $6.6B to $6.9B in fiscal year 2025.

Is Rentokil Initial Plc profitable?

Yes, Rentokil Initial Plc (RTO) reported a net income of $470.0M in fiscal year 2025, with a net profit margin of 6.8%.

How much debt does Rentokil Initial Plc have?

As of fiscal year 2025, Rentokil Initial Plc (RTO) had $2.3B in cash and equivalents against $392.0M in long-term debt.

What is Rentokil Initial Plc's net profit margin?

Rentokil Initial Plc (RTO) had a net profit margin of 6.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Rentokil Initial Plc's return on equity (ROE)?

Rentokil Initial Plc (RTO) has a return on equity of 8.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Rentokil Initial Plc's free cash flow?

Rentokil Initial Plc (RTO) generated $764.0M in free cash flow during fiscal year 2025. This represents a 17.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Rentokil Initial Plc's operating cash flow?

Rentokil Initial Plc (RTO) generated $972.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Rentokil Initial Plc's capital expenditures?

Rentokil Initial Plc (RTO) invested $208.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Rentokil Initial Plc have outstanding?

Rentokil Initial Plc (RTO) had 2.53B shares outstanding as of fiscal year 2025.

What is Rentokil Initial Plc's current ratio?

Rentokil Initial Plc (RTO) had a current ratio of 1.16 as of fiscal year 2025, which is considered adequate.

What is Rentokil Initial Plc's debt-to-equity ratio?

Rentokil Initial Plc (RTO) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Are Rentokil Initial Plc's earnings high quality?

Rentokil Initial Plc (RTO) has an earnings quality ratio of 2.07x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Rentokil Initial Plc?

Rentokil Initial Plc (RTO) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.